Like all Paragon Biosciences companies, Harmony has understood the importance of establishing a great workplace culture right from their start, with patients at the heart of all they do. In 2017, we at Paragon founded Harmony Biosciences using our proprietary Paragon Innovation Capital™ approach to accelerate development of life science breakthroughs. We identified a debilitating unmet need in neurology disorders of wakefulness, isolated a possible scientific solution and then created a company around it. Harmony was able to earn FDA approval and launch its first product in 2019.
Harmony is achieving its mission and ours, each and every day.